T&R Biofab: Preliminary consolidated earnings report

October 19, 2026 · KOSDAQ · Market cap ₩96.8bn · T&R Biofab chart & price →
AI reading
★★★ Neutral · Earnings

Posts Q3 preliminary results: revenue ₩8.91bn, down 6.6% from prior quarter

Key figures: Revenue ₩8.91bn

An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).

All of today's important filings (Filings Radar) →

For information only. Not investment advice.